Papers
1
Total Citations
7
H-Index
1
About
Dr. Pam Lee is a pioneering radiation oncologist whose work focuses on advancing stereotactic body radiotherapy (SBRT) for head and neck cancers, particularly early-stage glottic laryngeal cancer. Her most-cited study, "Phantom-to-clinic development of hypofractionated SBRT for early-stage glottic laryngeal cancer" (2017, 7 citations), represents a landmark translational effort that bridges preclinical phantom modeling with clinical application. This work demonstrates her commitment to optimizing radiation delivery techniques that reduce treatment duration while maintaining tumor control and minimizing toxicity to critical structures like the vocal cords. Dr. Lee’s contributions are particularly significant given the delicate balance required in laryngeal cancer treatment, where preserving voice function is paramount. Her research has helped establish hypofractionated SBRT as a viable, patient-friendly alternative to conventional fractionation, offering shorter treatment courses that improve patient convenience and healthcare resource utilization. While her citation count reflects the emerging nature of this field, her work has already influenced clinical protocols and inspired further investigation into SBRT for other head and neck subsites. Dr. Lee’s dedication to translating laboratory insights into tangible clinical benefits underscores her role as an innovator in modern radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1